Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology, in collaboration with partners from Germany, the UK and USA, have developed and validated an autonomous artificial intelligence (AI) agent capable of supporting clinical decision-making in oncology. The findings were published in the journal Nature Cancer. In the future, AI agents could assist healthcare professionals in navigating complex medical data and supporting informed, personalized treatment decisions for cancer patients.

Researchers from the SmartVote project, in which Universidad Carlos III de Madrid (UC3M) participates, have carried out a study that analyses the impact of digital disinformation in electoral processes in both Spain and Portugal. The report reveals a growing social concern about information manipulation, but also shows the high degree of scepticism among Generation Z (those aged between 18 and 24) towards traditional sources of information and new tools based on artificial intelligence (AI).

During the first meeting of the Global Think-tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global Health (ISGlobal) and held in the Palau Macaya of Barcelona on 5–6 June, more than 100 international experts issued a stark warning: millions of people will continue to go unseen by healthcare systems unless early detection and person-centred care for liver disease are prioritised without delay.

Nearly one-third of people who adopted and adhered to a healthy diet did not lose any weight, but still reaped many health benefits, according to a new study led by researchers at Harvard T.H. Chan School of Public Health and Ben Gurion University, Israel. Independent of weight reduction, study participants showed significant improvements in cardiometabolic markers, including higher HDL cholesterol (the healthy type of cholesterol), lower levels of leptin (the hormone that signals hunger), and less visceral fat (belly fat found deep inside the abdominal cavity, sometimes wrapping around organs).

  An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical technologies. That is the takeaway from a new report issued to the FDA, published this week in the open-access journal PLOS Medicine by Leo Celi of the Massachusetts Institute of Technology, and colleagues.